Definitive confirmation of ZIKV autochthonous transmission remains challenging because of the short window of RNA detectability following infection, cross-reactivity and persistent detectability of IgM antibodies, and the challenges of plaque reduction neutralization tests to confirm ZIKV infection and exclude cross-reactivity from other circulating flaviviruses. The gene discussed is CD40LG; the disease is Zika virus infectious disease.